Cover Image

CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1‐mutated breast cancer cells

Abstract For patients carrying BRCA1 mutations, at least one‐third develop triple negative breast cancer (TNBC). Not only is TNBC difficult to treat due to the lack of molecular target receptors, but BRCA1 mutations (BRCA1m) also result in chemotherapeutic resistance, making disease recurrence more...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachel L. Mintz (Author), Yeh‐Hsing Lao (Author), Chun‐Wei Chi (Author), Siyu He (Author), Mingqiang Li (Author), Chai Hoon Quek (Author), Dan Shao (Author), Boyuan Chen (Author), Jing Han (Author), Sihong Wang (Author), Kam W. Leong (Author)
Format: Book
Published: Wiley, 2020-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items